We are live on ! Find out more
RPRX

Repros Therapeutics Inc.
RPRX

Delisted

RPRX was delisted on the 31st of January, 2018.

Back to rankings

64 hedge funds and large institutions have $106M invested in Repros Therapeutics Inc. in 2015 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 16 increasing their positions, 21 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more call options, than puts

Call options by funds: $3.18M | Put options by funds: $2.96M

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11% less funds holding

Funds holding: 72 → 64 (-8)

21% less capital invested

Capital invested by funds: $135M → $106M (-$28.6M)

24% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 21

32% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 25

Holders
64
Holders Change
-8
Holders Change %
-11.11%
% of All Funds
1.72%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
16
Reduced
21
Closed
25
Calls
$3.18M
Puts
$2.96M
Net Calls
+$221K
Net Calls Change
-$5.18M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.87M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.57M
3
Bank of America
Bank of America
North Carolina
+$1.22M
4
Morgan Stanley
Morgan Stanley
New York
+$1.15M
5
Millennium Management
Millennium Management
New York
+$775K

Top Sellers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
-$4.91M
2
CC
CQS Cayman
Cayman Islands
-$3.58M
3
State Street
State Street
Massachusetts
-$2.64M
4
SAM
Senzar Asset Management
New York
-$2.1M
5
FCM
Farallon Capital Management
California
-$1.72M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$877K +$437K +56,142 +84%
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$844K +$499K +64,000 +119%
CS
28
Credit Suisse
Switzerland
$794K +$640K +82,104 +283%
GC
29
Guggenheim Capital
Illinois
$755K +$16.6K +2,126 +2%
JGC
30
J. Goldman & Co
New York
$728K -$297K -38,119 -27%
PP
31
PDT Partners
New York
$511K +$4.67K +600 +0.8%
BFA
32
BlackRock Fund Advisors
California
$442K -$4.91M -630,636 -91%
Jane Street
33
Jane Street
New York
$382K +$416K +53,423 New
TCIM
34
TIAA CREF Investment Management
New York
$367K -$680K -87,331 -63%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$342K -$757K -97,214 -67%
AQR Capital Management
36
AQR Capital Management
Connecticut
$337K -$279K -35,803 -43%
COPPSERS
37
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$309K +$336K +43,183 New
SM
38
Sabby Management
Florida
$298K +$324K +41,643 New
NCCM
39
Nine Chapters Capital Management
New Jersey
$298K +$325K +41,700 New
PP
40
Paloma Partners
Connecticut
$267K +$291K +37,400 New
LP
41
LMR Partners
United Kingdom
$170K +$185K +23,705 New
State Street
42
State Street
Massachusetts
$161K -$2.64M -339,489 -94%
Squarepoint
43
Squarepoint
New York
$134K +$146K +18,800 New
AGM
44
Alpine Global Management
New York
$124K +$135K +17,385 New
Barclays
45
Barclays
United Kingdom
$122K -$265K -34,021 -66%
HCM
46
Highbridge Capital Management
New York
$116K -$263K -33,742 -68%
Parallax Volatility Advisers
47
Parallax Volatility Advisers
California
$100K +$109K +14,000 New
VKH
48
Virtu KCG Holdings
New York
$97K +$105K +13,518 New
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$95K +$104K +13,333 New
JP Morgan Chase
50
JP Morgan Chase
New York
$79K +$86.2K +11,068 New
1
2
3 4

RPRX Hedge Fund Activity: Q2 2015 in Review

64 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Repros Therapeutics Inc. (RPRX) for Q2 2015, worth a combined $106M — down 21% from $135M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of RPRX and 17 opened new positions — a net loss of 8 holders — while 21 trimmed existing stakes and 16 added.

The largest buyer was Fidelity Investments, adding an estimated $3.87M. The largest seller was BlackRock Fund Advisors, cutting an estimated $4.91M.

  • 64 institutional investors held Repros Therapeutics Inc. (RPRX) as of Q2 2015, down from 72 in Q1 2015.
  • Funds reported $106M of Repros Therapeutics Inc. stock for Q2 2015, down 21% quarter-over-quarter.
  • 17 funds opened new Repros Therapeutics Inc. positions in Q2 2015 and 25 closed out, a net change of -8 holders.
  • The largest Repros Therapeutics Inc. buyer in Q2 2015 was Fidelity Investments, an estimated $3.87M added.
  • The largest Repros Therapeutics Inc. seller in Q2 2015 was BlackRock Fund Advisors, an estimated $4.91M sold.

Based on aggregated 13F filings for Q2 2015.